AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Director's Dealing Mar 15, 2016

4924_dirs_2016-03-15_f580e9ea-102e-466f-bd5e-609f60495fef.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1553S

Assura PLC

15 March 2016

15 March 2016

Assura plc ("Assura" or the "Company")

Director/PDMR Shareholding

The Company announces that on 15 March 2016 Jonathan Murphy, Finance Director, transferred 52,267 ordinary shares of 10 pence each in the Company ("Ordinary Shares") into his SIPP account and 29,000 Ordinary Shares into his ISA account at an average price of 54.29 pence per Ordinary Share.  Following the transaction Mr. Murphy's beneficial holding remains unchanged at 957,517 Ordinary Shares, representing 0.06% of the Company's issued share capital.

This notification is made in accordance with DTR 3.1.4(1)(a).

- Ends -

For more information, please contact:

Assura plc Tel: 01925 420660
Orla Ball

Notes to Editors

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. It owns over 300 medical centres nationwide, serving over 3 million patients. At 30 September 2015, Assura's property portfolio was valued at £1,030 million.

Further information is available at www.assuraplc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBBGDXXUBBGLU

Talk to a Data Expert

Have a question? We'll get back to you promptly.